GAROFALO HEALTH CARE SPA (GHC.MI) Fundamental Analysis & Valuation

BIT:GHC • IT0005345233

5.25 EUR
-0.04 (-0.66%)
Last: Mar 9, 2026, 05:08 PM

This GHC.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GHC. GHC was compared to 33 industry peers in the Health Care Providers & Services industry. GHC has an average financial health and profitability rating. GHC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. GHC.MI Profitability Analysis

1.1 Basic Checks

  • GHC had positive earnings in the past year.
  • GHC had a positive operating cash flow in the past year.
  • GHC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years GHC had a positive operating cash flow.
GHC.MI Yearly Net Income VS EBIT VS OCF VS FCFGHC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.66%, GHC is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 9.57%, GHC is in line with its industry, outperforming 57.58% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 6.52%, GHC is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for GHC is in line with the industry average of 6.06%.
  • The 3 year average ROIC (4.41%) for GHC is below the current ROIC(6.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROIC 6.52%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
GHC.MI Yearly ROA, ROE, ROICGHC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.62%, GHC is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • GHC's Profit Margin has declined in the last couple of years.
  • GHC has a better Operating Margin (9.37%) than 78.79% of its industry peers.
  • GHC's Operating Margin has declined in the last couple of years.
  • GHC's Gross Margin of 44.90% is fine compared to the rest of the industry. GHC outperforms 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of GHC has remained more or less at the same level.
Industry RankSector Rank
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
GHC.MI Yearly Profit, Operating, Gross MarginsGHC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. GHC.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GHC is still creating some value.
  • GHC has about the same amout of shares outstanding than it did 1 year ago.
  • GHC has more shares outstanding than it did 5 years ago.
  • GHC has a better debt/assets ratio than last year.
GHC.MI Yearly Shares OutstandingGHC.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GHC.MI Yearly Total Debt VS Total AssetsGHC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • GHC has an Altman-Z score of 1.94. This is not the best score and indicates that GHC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.94, GHC is in line with its industry, outperforming 51.52% of the companies in the same industry.
  • GHC has a debt to FCF ratio of 70.49. This is a negative value and a sign of low solvency as GHC would need 70.49 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 70.49, GHC is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
  • GHC has a Debt/Equity ratio of 0.67. This is a neutral value indicating GHC is somewhat dependend on debt financing.
  • The Debt to Equity ratio of GHC (0.67) is better than 75.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Altman-Z 1.94
ROIC/WACC1
WACC6.49%
GHC.MI Yearly LT Debt VS Equity VS FCFGHC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that GHC should not have too much problems paying its short term obligations.
  • The Current ratio of GHC (1.16) is better than 60.61% of its industry peers.
  • GHC has a Quick Ratio of 1.12. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.12, GHC is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.12
GHC.MI Yearly Current Assets VS Current LiabilitesGHC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. GHC.MI Growth Analysis

3.1 Past

  • GHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.11%.
  • Measured over the past years, GHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.81% on average per year.
  • GHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.44%.
  • The Revenue has been growing by 18.92% on average over the past years. This is quite good.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.47% on average over the next years.
  • The Revenue is expected to grow by 1.51% on average over the next years.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GHC.MI Yearly Revenue VS EstimatesGHC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
GHC.MI Yearly EPS VS EstimatesGHC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

3

4. GHC.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • GHC is valuated correctly with a Price/Earnings ratio of 14.58.
  • Based on the Price/Earnings ratio, GHC is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • GHC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 16.24, GHC is valued correctly.
  • Based on the Price/Forward Earnings ratio, GHC is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.60, GHC is valued a bit cheaper.
Industry RankSector Rank
PE 14.58
Fwd PE 16.24
GHC.MI Price Earnings VS Forward Price EarningsGHC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GHC is valued a bit cheaper than the industry average as 78.79% of the companies are valued more expensively.
  • GHC's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. GHC is more expensive than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 145.8
EV/EBITDA 7.31
GHC.MI Per share dataGHC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GHC does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)4.23
PEG (5Y)1.65
EPS Next 2Y5.05%
EPS Next 3Y6.47%

2

5. GHC.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.62%, GHC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.61, GHC has a dividend in line with its industry peers.
  • GHC's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
GHC.MI Yearly Income VS Free CF VS DividendGHC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

GHC.MI Fundamentals: All Metrics, Ratios and Statistics

GAROFALO HEALTH CARE SPA

BIT:GHC (3/9/2026, 5:08:36 PM)

5.25

-0.04 (-0.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners10.79%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap473.55M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (28.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.58
Fwd PE 16.24
P/S 0.69
P/FCF 145.8
P/OCF 16.95
P/B 1.42
P/tB N/A
EV/EBITDA 7.31
EPS(TTM)0.36
EY6.86%
EPS(NY)0.32
Fwd EY6.16%
FCF(TTM)0.04
FCFY0.69%
OCF(TTM)0.31
OCFY5.9%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.23
PEG (5Y)1.65
Graham Number5.47
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROCE 9.13%
ROIC 6.52%
ROICexc 6.77%
ROICexgc 14.86%
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
FCFM 0.47%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Debt/EBITDA 2.47
Cap/Depr 94.13%
Cap/Sales 3.57%
Interest Coverage 6.62
Cash Conversion 30.7%
Profit Quality 10.18%
Current Ratio 1.16
Quick Ratio 1.12
Altman-Z 1.94
F-Score5
WACC6.49%
ROIC/WACC1
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%

GAROFALO HEALTH CARE SPA / GHC.MI FAQ

What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.


What is the valuation status for GHC stock?

ChartMill assigns a valuation rating of 3 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Overvalued.


How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?

GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.


What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.


What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.